Morin: Natural Flavonoid Antioxidant and Mitochondrial Energy Modulator

Executive Summary: Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a high-purity, natural flavonoid isolated from Maclura pomifera, exhibiting antioxidant, anti-inflammatory, and organoprotective effects [APExBIO C5297]. Its key mechanistic hallmark is inhibition of adenosine 5′-monophosphate deaminase (AMPD), resulting in improved mitochondrial energy metabolism in disease models (Yang et al., 2025). Morin additionally acts as a fluorescent probe for aluminum ions due to its chelating properties. It is soluble in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), but insoluble in water, and must be stored at -20°C for optimal stability. The compound is validated by HPLC, MS, and NMR for ≥96.81% purity.

Biological Rationale

Morin is a polyphenolic flavonoid structurally classified as 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one (CAS 480-16-0). It is found in Maclura pomifera and other botanical sources. Flavonoids function as antioxidants by scavenging reactive oxygen species and modulate inflammatory signaling pathways. Mitochondrial energy metabolism is central to cell survival, particularly in high-energy-demand tissues such as kidney podocytes, neurons, and cardiac cells. Disturbances in mitochondrial function are implicated in diabetes, neurodegeneration, and renal injury [Contrast: This article provides a more granular analysis of AMPD2 inhibition compared to previous overviews.].

Mechanism of Action of Morin

Morin directly inhibits adenosine 5′-monophosphate deaminase (AMPD), a key enzyme in the purine nucleotide cycle (PNC). AMPD catalyzes the deamination of AMP to IMP, influencing cellular ATP pools. Inhibition of AMPD by Morin (notably AMPD2 isoform) mitigates ATP depletion, improves mitochondrial ultrastructure, and reduces compensatory glycolytic activation in podocytes exposed to high fructose (Yang et al., 2025). Morin also demonstrates high-affinity binding to AMPD2 in molecular docking and siRNA validation assays confirm the mechanistic centrality of AMPD2. Additionally, Morin chelates Al³⁺ ions, resulting in fluorescence enhancement, which enables its use as a sensitive probe for aluminum detection [Contrast: This article uniquely integrates enzymatic and probe applications.].

Evidence & Benchmarks

• Morin treatment (20 μM, 24 h, in vitro) significantly reduced AMPD activity and restored mitochondrial function in fructose-exposed mouse podocyte clone-5 (MPC5) cells (Yang 2025, https://doi.org/10.3390/ph18121883).
• In high-fructose-fed rats, Morin (100 mg/kg/day, oral, 8 weeks) decreased podocyte foot process effacement and urinary albumin-to-creatinine ratio (UACR) (Yang 2025, https://doi.org/10.3390/ph18121883).
• Morin’s inhibitory effect on AMPD2 was confirmed via molecular docking (binding energy: -8.2 kcal/mol) and siRNA knockdown phenocopied Morin’s protection (Yang 2025, https://doi.org/10.3390/ph18121883).
• Morin is insoluble in water but soluble in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), facilitating use in cell-based assays (https://www.apexbt.com/morin.html).
• Morin’s purity is ≥96.81% (HPLC, MS, NMR) per APExBIO product documentation (https://www.apexbt.com/morin.html).

Applications, Limits & Misconceptions

Morin is established as a research tool in:

• Modeling mitochondrial dysfunction in diabetes, neurodegenerative, and renal disease research.
• Probing AMPD2-related metabolic pathways in glomerular podocyte injury models.
• Acting as a fluorescent chelator for aluminum ion detection in biochemical assays.

This article provides a mechanistic update to previous analyses by detailing Morin’s enzymatic targets and utility across disease models.

Common Pitfalls or Misconceptions

• Morin is not water soluble; improper dissolution may lead to inaccurate dosing (APExBIO).
• It is not a direct ATP synthase activator; its effect is mediated via AMPD inhibition, not direct mitochondrial enzyme activation (Yang 2025).
• Morin’s fluorescent chelation is selective for Al³⁺, not broadly applicable for all metal ions (see application notes).
• Preclinical bioactivities do not imply clinical efficacy; translational gaps remain (Yang 2025).
• Stability is temperature-dependent; room temperature storage degrades Morin (APExBIO).

Workflow Integration & Parameters

• Solubility: Dissolve Morin in DMSO or ethanol to ≥19.53 mg/mL and ≥6.04 mg/mL, respectively (APExBIO).
• Stability: Store powder at -20°C; solutions should be prepared fresh for short-term use only.
• Assay setup: Include vehicle controls due to DMSO/ethanol effects; consider final solvent concentration in culture media.
• Purity: Use high-purity validated lots (≥96.81%) to ensure reproducibility.
• Analytical uses: For aluminum detection, use established fluorescence protocols with Morin as chelator.

For expanded workflows and translational strategies, see this analysis (which benchmarks Morin against related flavonoids and highlights next-generation disease modeling potential).

Conclusion & Outlook

Morin (APExBIO C5297) is a validated, high-purity flavonoid tool compound for dissecting mitochondrial dysfunction and AMPD2-dependent metabolic pathways. Its dual capability—as both a bioactive modulator and a fluorescent probe—enables broad applications in diabetes, renal, and neurodegenerative disease models. While robust in preclinical settings, users must recognize solubility, specificity, and translational boundaries. Ongoing research will clarify Morin’s clinical relevance and expand its use in precision disease modeling.